Drug supply changes imminent

The U.S. government and other parties are stepping up efforts to protect the national drug distribution system from counterfeiting, terrorism and disruption from manmade and natural disasters, says a new report. Challenges include the dominance of three wholesalers, growth of mail order and the wave of pharmacy consolidation. "The U.S. supply chain is set to undergo great changes in the next decade," authors say. Summary

Suggested Articles

Novavax has inked a $60 million contract with the U.S. Department of Defense to help fund U.S.-based manufacturing of its COVID-19 vaccine candidate.

Vaccine maker Inovio has accused a longtime manufacturing partner of hampering its efforts to produce 1 million doses of a potential COVID-19 vaccine.

Roche's global manufacturing leader Pierre-Alain Ruffieux will take the reins and oversee the Moderna COVID-19 vaccine collaboration.